Lenalidomide Dosing and Outcomes in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

被引：0
|
作者：
Mian, Hira S. [1 ]
Leblanc, Richard [2 ]
Louzada, Martha L. [3 ]
Masih-Khan, Esther [4 ,5 ]
McCurdy, Arleigh [4 ,6 ]
Venner, Christopher P. [7 ]
Stakiw, Julie [8 ]
Kardjadj, Moustafa [9 ]
Jimenez-Zepeda, Victor H. [10 ]
Sebag, Michael [11 ]
White, Darrell J. [12 ,13 ]
Aslam, Muhammad [14 ]
Song, Kevin W. [15 ]
Reiman, Anthony [16 ]
Kotb, Rami [17 ]
Gul, Engin [9 ]
Reece, Donna E. [4 ,5 ]
机构：
[1] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
[2] Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada
[3] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
[4] Canadian Myeloma Res Grp, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[6] Ottawa Hosp, Div Hematol, Dept Med, Ottawa, ON, Canada
[7] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[8] Saskatoon Canc Ctr, Saskatoon, SK, Canada
[9] Canadian Myeloma Res Grp, Toronto, ON, Canada
[10] Univ Calgary, Dept Hematol, Tom Baker Canc Ctr, Calgary, AB, Canada
[11] McGill Univ, Div Hematol, Hlth Ctr, Montreal, PQ, Canada
[12] Dalhousie Univ, Halifax, NS, Canada
[13] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[14] Allan Blair Canc Ctr, Regina, SK, Canada
[15] BC Canc Agcy, Leukemia Bone Marrow Transplant Program British C, Vancouver, BC, Canada
[16] St Johns Hosp, Oncol, St John, NB, Canada
[17] Canc Care Manitoba, Med Oncol & Hematol, Winnipeg, MB, Canada
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4721
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database
    McCurdy, Arleigh
    Louzada, Martha
    Venner, Christopher P.
    Visram, Alissa
    Masih-Khan, Esther
    Kardjadj, Moustafa
    Jimenez-Zepeda, Victor H.
    LeBlanc, Richard
    Sebag, Michael
    Song, Kevin
    White, Darrell
    Mian, Hira
    Stakiw, Julie
    Reiman, Anthony
    Aslam, Muhammad
    Kotb, Rami
    Gul, Engin
    Reece, Donna
    [J]. EJHAEM, 2022, 3 (04): : 1252 - 1261
  • [2] Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database
    Jimenez-Zepeda, Victor H.
    Venner, Christopher
    McCurdy, Arleigh
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Sebag, Michael
    Stakiw, Julie
    Song, Kevin
    LeBlanc, Richard
    Reiman, Tony
    Louzada, Martha
    Kotb, Rami
    Gul, Engin
    Reece, Donna
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 532 - 541
  • [3] Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
    Cote, Julie
    Leblanc, Richard
    Chu, Michael P.
    McCurdy, Arleigh
    Masih-Khan, Esther
    Kardjadj, Moustafa
    Jimenez-Zepeda, Victor H.
    Song, Kevin
    Louzada, Martha L.
    Mian, Hira S.
    White, Darrell
    Sebag, Michael
    Reiman, Anthony
    Stakiw, Julie
    Kotb, Rami
    Bergstrom, Debra
    Aslam, Muhammad
    Kaedbey, Rayan
    Venner, Christopher P.
    Gul, Engin
    Reece, Donna E.
    [J]. BLOOD, 2022, 140
  • [4] Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
    McCurdy, Arleigh
    Venner, Christopher P.
    Louzada, Martha L.
    LeBlanc, Richard
    Sebag, Michael
    Song, Kevin W.
    Jimenez-Zepeda, Victor
    Kotb, Rami
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Mian, Hira S.
    White, Darrell J.
    Stakiw, Julie
    Aslam, Muhammad
    Reiman, Anthony
    Gul, Engin
    Reece, Donna E.
    [J]. BLOOD, 2020, 136
  • [5] Outcomes of transplant-ineligible myeloma patients using bortezomib/lenalidomide-containing regimens in the real world: a report from the Canadian Myeloma Research Group Database
    Kaedbey, Rayan
    Venner, Christopher
    McCurdy, Arleigh
    Masih-Khan, Esther
    Kardjadj, Moustafa
    Chu, Michael
    Louzada, Martha
    Jimenez-Zepeda, Victor
    LeBlanc, Richard
    Mian, Hira
    Song, Kevin
    Sebag, Michael
    Stakiw, Julie
    White, Darrell
    Reiman, Anthony
    Aslam, Muhammad
    Kotb, Rami
    Bergstrom, Debra
    Gul, Engin
    Reece, Donna E.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S145 - S146
  • [6] Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
    Facon, Thierry
    Venner, Christopher P.
    Bahlis, Nizar J.
    Offner, Fritz
    White, Darrell J.
    Karlin, Lionel
    Benboubker, Lotfi
    Rigaudeau, Sophie
    Rodon, Philippe
    Voog, Eric
    Yoon, Sung-Soo
    Suzuki, Kenshi
    Shibayama, Hirohiko
    Zhang, Xiaoquan
    Twumasi-Ankrah, Philip
    Yung, Godwin
    Rifkin, Robert M.
    Moreau, Philippe
    Lonial, Sagar
    Kumar, Shaji K.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    [J]. BLOOD, 2021, 137 (26) : 3616 - 3628
  • [7] Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
    Mian, Hira
    LeBlanc, Richard
    Louzada, Martha
    Masih-Khan, Esther
    McCurdy, Arleigh
    Venner, Christopher P.
    Stakiw, Julie
    Kardjadj, Moustafa
    Jimenez-Zepeda, Victor H.
    Sebag, Michael
    White, Darrell
    Aslam, Muhammad
    Song, Kevin
    Reiman, Anthony
    Kotb, Rami
    Gul, Engin
    Reece, Donna
    [J]. CANCER MEDICINE, 2023, 12 (04): : 4357 - 4362
  • [8] Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database
    Kaedbey, Rayan
    Reece, Donna
    Venner, Christopher P.
    Mccurdy, Arleigh
    Su, Jiandong
    Chu, Michael
    Louzada, Martha
    Jimenez-Zepeda, Victor H.
    Mian, Hira
    Song, Kevin
    Sebag, Michael
    Stakiw, Julie
    White, Darrell
    Reiman, Anthony
    Aslam, Muhammad
    Kotb, Rami
    Bergstrom, Debra
    Gul, Engin
    Leblanc, Richard
    [J]. EJHAEM, 2024, 5 (03): : 474 - 484
  • [9] Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews
    Visacri, Manlia Berlofa
    Ribeiro, Mayra Carvalho
    Komoda, Denis Satoshi
    Duarte, Bruno Kosa Lino
    Correa, Carlos Roberto Silveira
    Maia, Flavia de Oliveira Motta
    Alves, Daniela Fernanda dos Santos
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
  • [10] Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi- Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
    McCurdy, Arleigh
    Gul, Engin
    Reece, Donna
    Venner, Christopher P.
    White, Darrell
    Su, Jiandong
    Chu, Michael P.
    Jimenez-Zepeda, Victor H.
    Song, Kevin
    Mian, Hira
    Sebag, Michael
    Bergstrom, Debra
    Stakiw, Julie
    Reiman, Anthony
    Kotb, Rami
    Aslam, Muhammad
    Kaedbey, Rayan
    Louzada, Martha L.
    LeBlanc, Richard
    [J]. BLOOD, 2023, 142
12345